[1]
Kılıçaslan, U. and Hapa, F.A. 2026. Retrospective Analysis of Demographic and Clinical Data of Psoriasis Patients Who Developed Inflammatory Bowel Disease Under Secukinumab and Ixekizumab Treatment. Dermatology Practical & Conceptual. 16, (Apr. 2026), 7125. DOI:https://doi.org/10.5826/dpc.160a7125.